In our study, analysis of IL-21 mRNA and protein levels of immune cells and AML cells combined with adoptive transfer experiments of CD4+ T cells identified CD4+ T cells as the primary source of IL-21 and CD4+ T cell-derived IL-21 as a negative regulator of stemness in AML. This evidence concerns the gene CD4 and acute myeloid leukemia.